J&J Investors Score Class Cert. In Talc Concealment Suit
A New Jersey federal judge has certified a class of Johnson & Johnson investors who claim the company artificially inflated its stock price by failing to disclose cancer risks associated with...To view the full article, register now.
Already a subscriber? Click here to view full article